https://www.selleckchem.com/products/cddo-im.html
After propensity score matching, 180 patients remained in each group. There was no difference in risk of CSA-AKI between the two groups (RR=1.15; 95% CI, 0.85-1.56, p=0.36). The in-hospital mortality, H-LOS and cardiovascular complications were higher in the LFB group. ICU-LOS was not significantly different between the two groups. ROCcurve analysis determined a fluid balance above 2500 mL to accurately predict in-hospital mortality. Patients undergoing on-pump CABG with LFB when compared with patients with RFB present similar CSA-AKI r